Pharmaceutical

Medical Care Technologies (OTC PINK:MDCE) Initiates Preparatory Phase for Self-Conducted Research Studies on AI Mental Health and Preventive Biometrics Modules

MESA, ARIZONA / ACCESS Newswire / October 8, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE), an emerging innovator in…

3 months ago

Aptevo Presenting Scientific and Clinical Updates at SITC and ASH, also Participating in Leading Financial and Industry Conferences in the Fourth Quarter

SEATTLE, WASHINGTON / ACCESS Newswire / October 8, 2025 / Aptevo Therapeutics ("Aptevo" or the "Company") (Nasdaq:APVO), a clinical-stage biotechnology…

3 months ago

NeoPredics Announces Market Launch of PreFree Across CE-Markets

- Clinical challenge: uncertainty in discharge and admission decisions for women at risk of preeclampsia- PreFree: the first CE-marked, multimodal…

3 months ago

Rising Demand for Revision Rhinoplasty Leads Patients Worldwide to Dr. Shervin Naderi

The Naderi Center sees growing demand for revision rhinoplasty, with Dr. Shervin Naderi providing surgical and non-surgical solutions customized to…

3 months ago

Rezolut Launches SubtleHD: More Comfortable MRI Scans, Sharper Results

ATLANTA, GEORGIA / ACCESS Newswire / October 8, 2025 / Rezolut LLC, a national leader in advanced diagnostic imaging, is…

3 months ago

Leaders Named in Accountable Care and Value-Based Care Technology and Advisory Ecosystem

Black Book Survey results reveal the twenty-five firms shaping the next generation of accountable care infrastructure  released in orchestration with…

3 months ago

Silo Pharma Expands Crypto Treasury with First Strategic Bitcoin Purchase Reinforcing Company’s Commitment to Multi-Chain Growth

SARASOTA, FL, Oct. 08, 2025 (GLOBE NEWSWIRE) --   Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the Company), a diversified…

3 months ago

Journey Medical Corporation to Participate in October 2025 Investor Conferences

SCOTTSDALE, Ariz., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage…

3 months ago

Sapu Nano Unveils First-in-Human Clinical Trial of Sapu-003 at 8th Australian Translational Breast Cancer Research Symposium

Using Sapu Nano’s proprietary Deciparticle™ technology, Sapu-003 delivers everolimus intravenouslySYDNEY, Australia, Oct. 08, 2025 (GLOBE NEWSWIRE) -- via IBN –…

3 months ago

NurExone Demonstrates Reproducible, Dose-Dependent Vision Recovery in Preclinical Glaucoma Model

Accelerates Warrant Expirations and POSITIVE Communications ExtensionTORONTO and HAIFA, Israel, Oct. 08, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX)…

3 months ago